Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Cathleen A. Cantwell is active.

Publication


Featured researches published by Cathleen A. Cantwell.


Gene | 1994

THE BACILLUS SUBTILIS PNBA GENE ENCODING P-NITROBENZYL ESTERASE : CLONING,SEQUENCE AND HIGH-LEVEL EXPRESSION IN ESCHERICHIA COLI

Joseph Martin Zock; Cathleen A. Cantwell; James R. Swartling; Roland L. Hodges; Tonya Pohl; Kimberly Sutton; Paul Robert Rosteck; Derek Mcgilvray; Stephen Wyatt Queener

p-Nitrobenzyl esters serve as protecting groups on intermediates in the manufacture of clinically important oral beta-lactam antibiotics; de-esterification of the intermediates is required for synthesis of the final product. A Bacillus subtilis PNB carboxy-esterase (PNBCE) catalyzes hydrolysis of several beta-lactam antibiotic PNB esters to the corresponding free acid and PNB alcohol. This communication (i) describes cloning the pnbA gene, which encodes PNBCE, (ii) provides the nucleotide sequence of the pnbA open reading frame (ORF) and (iii) describes a method for efficiently expressing the ORF in Escherichia coli. The amino acid (aa) sequence, deduced from the nucleotide sequence of the pnbA ORF, matched an experimentally determined N-terminal aa sequence of B. subtilis PNBCE and also matched an active site sequence previously identified by biochemical analyses. Specific activity of PNBCE in crude extracts was more than 90-fold greater in recombinant E. coli, as compared to B. subtilis. This increase in expression led to more than a 500-fold improvement in the efficiency of purification of PNBCE.


Current Genetics | 1990

Cloning and expression of a hybrid Streptomyces clavuligerus cefE gene in Penicillium chrysogenum

Cathleen A. Cantwell; Robert John Beckmann; Joe Edward Dotzlaf; Deborah L. Fisher; Paul Luther Skatrud; Wu-Kuang Yeh; Stephen Wyatt Queener

SummaryA hybrid cefE gene was constructed by juxtaposing promoter sequences from the Penicillium chrysogenum pcbC gene to the open reading frame of the Streptomyces clavuligerus cefE gene. In S. clavuligerus the cefE gene codes for the enzyme penicillin N expandase [also known as deacetoxycephalosporin C synthetase (DAOCS)]. To insert the hybrid cefE gene into P. chrysogenum the vector pPS65 was constructed; pPS65 contains the hybrid cefE gene and the Aspergillus nidulans amdS gene. The amdS gene encodes acetamidase and provides for dominant selection in P. chrysogenum. Protoplasts of P. chrysogenum were transformed with pPS65 and selected for the ability to grow on acetamide medium. Extracts of cells cultivated in penicillin production medium were analyzed for penicillin N expandase activity. Penicillin N expandase activity was detected in approximately one-third of the transformants tested. Transformants WG9-69C-01 and WG9-61L-03 had the highest specific activities of penicillin N expandase: 4.3% and 10.3%, respectively, relative to the amount of penicillin N expandase in S. clavuligerus. Untrasformed P. chrysogenum exhibited no penicillin N expandase activity. Analysis of the penicillin V titer revealed that WG9-61L-03 produced titers equal to that of the recipient strain while the amount of penicillin V produced in WG9-69C-01 was reduced by five fold.


Proceedings of the Royal society of London. Series B. Biological sciences | 1992

Isolation of deacetoxycephalosporin C from fermentation broths of Penicillium chrysogenum transformants: construction of a new fungal biosynthetic pathway.

Cathleen A. Cantwell; Robert John Beckmann; Patricia Whiteman; Stephen Wyatt Queener; E. P. Abraham

Deacetoxycephalosporin C (DAOC), a precursor of cephalosporins excreted by Cephalosporium and Streptomyces species, has been produced in Penicillium chrysogenum transformed with DNA containing a hybrid penicillin N expandase gene (cefEh) and a hybrid isopenicillin N epimerase gene (cefDh). DAOC from a P. chrysogenum transformant was identified by ultraviolet light (uv), high performance liquid chromatography (HPLC), nuclear magnetic resonance (NMR) and mass spectrum analyses. P. chrysogenum transformed with DNA containing cefEh without cefDh did not produce DAOC. Untransformed P. chrysogenum produced penicillin V (phenoxymethylpenicillin) but not DAOC. Transformants also produced penicillin V but, in general, less than untransformed P. chrysogenum. The cefEh and cefDh genes were constructed by replacing the open reading frame (ORF) of clonedP. chrysogenum pcbC and penDE genes with the ORF of the Streptomyces clavuligerus expandase gene, cefE, and the ORF of the Streptomyces lipmanii epimerase gene, cefD, respectively. Analyses of representative transformants suggested that production of DAOC occurred via cefEh and cefDh genes stably integrated in the P. chrysogenum genome. DNA from untransformed P. chrysogenum did not hybridize to cefE or cefD gene probes.


Current Genetics | 1990

Gene disruption of the pcbAB gene encoding ACV synthetase in Cephalosporium acremonium.

Jo Ann Hoskins; Niamh O'Callaghan; Stephen Wyatt Queener; Cathleen A. Cantwell; John S. Wood; Victor J. Chen; Paul Luther Skatrud

SummaryPlasmid pPS 96 was used to disrupt the genomic region immediately upstream of pcbC in C. acremonium by homologous integration. Approximately 4% of the C. acremonium transformants obtained with pPS 96 were unable to produce beta-lactam antibiotics. All transformants obtained with other plasmids and isolates which had not been exposed to transforming DNA retained the ability to produce beta-lactams. Enzyme analysis showed that ACV synthetase activity was missing in the beta-lactam-minus pPS 96 transformants. Southern hybridization analysis confirmed the presence of multiple copies of pPS 96 in all beta-lactam-minus transformants analyzed. However, predictable alterations of the targeted region were not detected. Transformation of antibioticminus transformants with plasmid pZAZ4, carrying a wild-type copy of the region targeted for disruption, resulted in restoration of the ability to produce beta-lactams in greater than 80% of the transformants recovered. Location of the pcbAB gene upstream from pcbC was confirmed by comparing the amino acid sequence of internal peptides from purified ACV synthetase with that deduced from the DNA sequence of the region targeted for disruption. The direction of transcription of the pcbAB gene is opposite that of the pcbC gene. Further analysis of amino acid sequence data from ACV synthetase revealed regions of strong similarity with the peptide synthetases responsible for production of tyrocidine and gramicidin S in Bacillus brevis.


Antonie Van Leeuwenhoek International Journal of General and Molecular Microbiology | 1997

Applications of transposition mutagenesis in antibiotic producing streptomycetes.

Richard H. Baltz; Margaret Ann Mchenney; Cathleen A. Cantwell; Stephen Wyatt Queener; Patricia J. Solenberg

Several transposons have been developed from the streptomycete insertion sequence IS493. They have broad host specificity in Streptomyces species and insert relatively randomly into a consensus target sequence of gNCaNTgNNy. Collectively, they have specialized features that facilitate the following: cloning of DNA flanking insertions; physical mapping of insertions; construction of highly stable mutants; and efficient construction of mutant libraries. All of the transposons can be introduced into streptomycetes by conjugation from E. coli, and can be delivered by curing the temperature sensitive delivery plasmid. Tn5099 was used to physically map genes involved in daptomycin and red pigment production in Streptomyces roseosporus, and to clone daptomycin biosynthetic genes. Tn5099 was also used in Streptomyces fradiae to identify and clone a neutral genomic site for the insertion of a second copy of the tylF gene. Recombinants containing two copies of the tylF gene carried out the no rmally rate limiting conversion of macrocin to tylosin very efficiently, thus causing substantial increases in tylosin yield.


Gene | 1996

TRANSPOSITION MUTAGENESIS IN STREPTOMYCES FRADIAE : IDENTIFICATION OF A NEUTRAL SITE FOR THE STABLE INSERTION OF DNA BY TRANSPOSON EXCHANGE

Patricia J. Solenberg; Cathleen A. Cantwell; Anthony Joseph Tietz; Derek Mc Gilvray; Stephen Wyatt Queener; Richard H. Baltz

We explored transposition in Streptomyces fradiae (Sf) as a means to insert a second copy of the tylF gene to improve tylosin (Ty) production. Transposons Tn5096 and Tn5099 transposed relatively randomly in Sf, and many of the insertions caused no deleterious effects on Ty production yields. Tn5098, a derivative of Tn5096 containing tylF and tylJ genes, recombined into the chromosome into the tyl gene cluster and transposition was not observed. However, following the tagging of a neutral site (NS) by Tn5099 transposition, tylF was effectively inserted into the NS by homologous recombination (transposon exchange). Recombinants obtained by transposon exchange produced higher yields of Ty.


Archive | 1992

Genetic Manipulation of the β-lactam Antibiotic Biosynthetic Pathway

Paul Luther Skatrud; JoAnn Hoskins; John S. Wood; Matthew B. Tobin; James Robert Miller; Stephen Kovacevic; Cathleen A. Cantwell; Stephen Wyatt Queener

Penicillins and cephalosoporins are members of the large group of sulfur-containing β-lactam antibiotics. Biosynthesis of the naturally occurring β-lactams, penicillin G, and cephalosporin C is illustrated in Figure 3.1. The key structural similarity of these heterocyclic compounds is the four-membered β-lactam ring (illustrated in the inset in Fig. 3.1), which is fused to a five-membered thiazolidine ring in penicillin G or a six-membered dihydrothiazine ring in cephalosporin C. Because of this structural similarity, the mode of action of all β-lactam antibiotics is the same: they interfer with bacterial cell wall synthesis and cause death by cell lysis. Penicillin G has been modified chemically to form many other clinically useful antibiotics that extended the spectrum of activity and, in some cases, provided resistance to penicillinases encoded by resistant pathogens. Although naturally resistant to penicillinases, cephalosporin C is not used clinically. However, chemical modifications of cephalosporin C have produced a variety of clinically useful agents, further extending the activity spectrum of β-lactam compounds.


Nature Biotechnology | 1989

Use of Recombinant DNA to Improve Production of Cephalosporin C By Cephalosporium acremonium

Paul Luther Skatrud; Anthony Joseph Tietz; Thomas D. Ingolia; Cathleen A. Cantwell; Deborah L. Fisher; Jerry L. Chapman; Stephen Wyatt Queener


Annals of the New York Academy of Sciences | 1994

Improved expression of a hybrid Streptomyces clavuligerus cefE gene in Penicillium chrysogenum.

Stephen Wyatt Queener; Robert John Beckmann; Cathleen A. Cantwell; Roland L. Hodges; Deborah L. Fisher; Joe Edward Dotzlaf; Wu-Kuang Yeh; Derek Mcgilvray; Michael Greaney; Paul Robert Rosteck


Archive | 1993

Recombinant DNA compounds and expression vectors encoding para-nitrobenzyl esterase activity from bacillus

Cathleen A. Cantwell; Roland L. Hodges; Derek Mcgilvray; Stephen Wyatt Queener; James R. Swartling; Joseph Martin Zock

Collaboration


Dive into the Cathleen A. Cantwell's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge